drugset / Trial / NCT03252457

Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP

NCT03252457

RandomizedParallel-groupOpen-labelTreatment

Summary

The project was undertaking by Qilu Hospital of Shandong University and other 18 well-known hospitals in China. In order to report the efficacy and safety of decitabine combining with dexamethasone for the treatment of adults with immune thrombocytopenia (ITP), compared to dexamethasone alone .

Timeline

Start
2018-09-01
Primary completion
2020-12-01
Completion
2021-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Decitabine Small molecule 3.5 mg/m2 Intravenous
Subject Dexamethasone Small molecule 40 mg